Results 101 to 110 of about 25,922 (158)

[Twenty years since the publication of medication price regulation in Brazil: time to update?] [PDF]

Cad Saude Publica
Melo VA, Santana RS, Galato D.
europepmc   +1 more source

[Evaluating, improving and monitoring generic drug prescription]. [PDF]

Aten Primaria, 2002
López-Picazo Ferrer JJ, Sanz Moreno JA, Bernal Montañés JM, Sánchez Ruiz JF.   +3 more
europepmc   +1 more source

[HEARTS quality: a policy framework to strengthen hypertension and cardiovascular risk management in primary healthcare - insights from HEARTS in the AmericasQualidade da iniciativa HEARTS: marco de políticas para fortalecer o manejo da hipertensão e do risco cardiovascular na atenção primária à saúde. Perspectivas da iniciativa HEARTS nas Américas]. [PDF]

Rev Panam Salud Publica
Londoño E, Gupta R, Van der Stuyft P, Heine M, Giraldo G, Ku GM, Brettler J, Rosende A, Irazola V, Toelsie J, Neira C, Aumala T, Valdés Y, Zúñiga E, Rodríguez L, Villatoro M, Escobar MC, Pérez V, Bencomo A, Pereira M, de la Rosa A, Ordunez P.   +21 more
europepmc   +1 more source

[Commentary: Problems with increasing the use of generic drugs in Spain]. [PDF]

Aten Primaria, 2002
Azagra Ledesma R, Aguyé Batista A.
europepmc   +1 more source

[The HEARTS app: a clinical tool for cardiovascular risk and hypertension management in primary health careO aplicativo HEARTS: uma ferramenta clínica para o gerenciamento de risco cardiovascular e hipertensão na atenção primária à saúde]. [PDF]

Rev Panam Salud Publica, 2022
Ordunez P, Tajer C, Gaziano T, Rodríguez YA, Rosende A, Jaffe MG.   +5 more
europepmc   +1 more source

Protección de la Competencia en Chile: El Estado y Laboratorios Chile y Recalcine (1992-93) [PDF]

In 1992, Laboratorios Chile and Recalcine, the two largest pharmaceutical companies in Chile with a share of 82% of the domestic markets for generic products, were accused of collusion.
Edgardo Barandiarán, Ricardo Paredes
core  

Comparative evaluation of dissolution profiles of the generic drug lamivudine 150 mg tablet marketed in Peru vs. the innovative Epivir. [PDF]

Rev Peru Med Exp Salud Publica
Castañeda-Alarcón M, García-Montoya E, Rodríguez-Calzado J, Flores-Rodríguez M, Grande-Ortíz M, Moreno-Exebio L.   +5 more
europepmc   +1 more source

[Do we primary care doctors improve our prescription of generic medicines after the intervention of the area pharmacist?]. [PDF]

Aten Primaria, 2006
Gandía-Moya MC.
europepmc   +1 more source

[Utilization of generic drugs in Spain and Catalonia: possibilities of savings]. [PDF]

Aten Primaria, 2000
Torralba Guirao M, Gilabert Perramon A, Peláez de Loño J, Faixedas Brunsoms MT.   +3 more
europepmc   +1 more source

Knowledge, attitudes and practices taeniasis/cysticercosis caused by Taenia solium among students and professionals of Bioanalysis in Maracay, Venezuela, 2020 [PDF]

Biomedica
Rojas GC, Aouad M, Barrios Y, Cortez MM.
europepmc   +1 more source